Does BPC-157 Help A2 Pulley Injuries?
Does BPC-157 help an A2 pulley injury? There’s no settled answer — just a debate. Climbers who try it say the peptide takes the edge off a healing pulley and gets them crimping again sooner, on the idea that BPC-157 speeds tendon and ligament repair. Skeptics push back that the story leans on a rat-tendon study rather than a human finger, and that a torn pulley heals on its own clock either way. Below is both sides — plus how the injury gets graded, since that’s what climbers argue over first.
The full rundown — grading, the case for BPC-157, and the case against ↓
Felt a pop on a crimp? You may have hurt a pulley. The A2 pulley, near the base of the finger, takes the most load on a crimp, so it’s the one climbers hurt most.
What is an A2 pulley injury?
Doctors grade these from I to IV:
- Grade I — a strain, no tear.
- Grade II — one pulley torn.
- Grade III — one torn, plus damage nearby.
- Grade IV — several torn, often with bowstringing (the tendon lifting off the bone).
A few things set your path from here:
- The grading system comes from Volker Schöffl’s team, built from real climbing injuries.[1]
- The grade sets your timeline — and whether surgery is even a question.
- An ultrasound, not how it felt, is what confirms it.[2]
What are BPC-157 and TB-500?
- BPC-157 is a lab-made peptide sold online for tissue repair. The name is short for “Body Protection Compound,” and its recipe comes from a protein found in human stomach fluid.
- TB-500 is usually sold with it — the pair is nicknamed the Wolverine stack. It’s a lab-made fragment of a natural protein called thymosin β4, which has been through human trials only for dry eye, given as an eye drop.[4]
Why do climbers use it for a pulley injury?
The logic climbers and sellers work from is simple: a torn pulley is a repair job, and BPC-157 is described in lab research as acting on the machinery that repair depends on. The specific claims:
- Tendon cell growth. A 2011 lab study found BPC-157 helped tendon cells (tenocytes) move, grow, and survive stress in a dish.[8]
- New blood vessels. Part of the reasoning is angiogenesis — growing new blood vessels. On the Huberman Lab podcast, that effect was described as its proposed healing mechanism[12] — which appeals to climbers because the pulley is a thin band with little blood supply to begin with.
- Healing a cut tendon. A 2006 rat study found BPC-157 helped a surgically cut Achilles tendon heal.[7]
- The TB-500 angle. Thymosin β4, the protein TB-500 is a piece of, is described in the research as a protein that helps repair injured tissue[3] — and users apply that to the pulley.
What climbers actually use it for, going by their posts:
- A pulley that popped on a crimp and hasn’t settled with rest.
- A grade II or III tear they’re managing without surgery.
- Most often, the long stretch between the injury and hard climbing, where they want to shorten the timeline.
How do people use it?
- On peptide forums like MESO-Rx and LongeCity, users describe injecting BPC-157 — often stacked with TB-500 — for tendon and joint injuries.[5]
- Fake or underdosed product is a constant worry.
- Some users even crowdfund third-party lab testing to check what’s actually in their vials.[6]
What do users report?
Reports on peptide forums are mixed — some describe fast relief, others say it did nothing.[5][10]
What some users report (anecdotal)
- Faster pain relief
- More energy
- Quicker return to climbing
What other users report (anecdotal)
- No effect at all
- Wasted money on fakes
- Doubts it does anything
Two things worth keeping in mind about these:
- They’re self-selected reports from anonymous posters, not measured outcomes.
- Pulley injuries also heal on their own over time — and BPC-157 is almost always taken with TB-500, so a report rarely separates one from the other.
What side effects are reported?
BPC-157 has no formal safety studies in people, so there’s no official side-effect list — just forum reports and expert caution. (One account’s tally of 106 community self-reports on X found about 55% said their problem improved and about 17% said they got worse overall.)
Reported by forum users (anecdotal)
- Injection-site pain, redness
- Nausea
- Heart palpitations
- Fatigue
- Mood changes
- Emotional blunting (anhedonia)
- Headaches
- Dizziness
- Metallic taste
- Under-eye puffiness
Off-label upsides some users report (anecdotal)
- Better mood
- Less anxiety
- Hair growth
- Clearer skin
- Fewer alcohol cravings
A few specifics from the forums:
- Users on Reddit’s r/bpc_157, r/Peptides, and r/TBI describe heart palpitations and a jump in resting heart rate — one reported it climbing from 66 to 96 bpm all day, with dull chest pain.
- Another, in r/TBI, described a severe inflammatory reaction — “joint inflammation so bad I can barely walk” — after trying BPC-157 from two different sources, both oral and injected.
- Emotional blunting (anhedonia — a flat, joyless feeling) shows up in dedicated threads; users tie it to BPC-157’s effect on dopamine, and some say it eases over days to weeks after they stop.
- Purity is all over the map — gray-market testing has found some BPC-157 as low as about 55% pure.
And from people with a public platform:
- Physician Peter Attia puts BPC-157 in his lowest-confidence group, noting its animal results haven’t been repeated in people.[11]
- On the Huberman Lab podcast, the main concerns raised were product sourcing and a theoretical cancer risk, since BPC-157 can promote blood-vessel growth.[12]
- In 2023, the FDA placed BPC-157 in a restricted compounding category, citing concerns like immune reactions and impurities.[13]
What’s the standard approach to a pulley injury?
For context on what a peptide would sit alongside or instead of:
- Get the grade right. Ultrasound, not guessing, sets the timeline.[2]
- Load it, don’t just rest it. Tendon tissue responds to gradual load, not only time off.[14]
- Tape and no-hangs. H-taping and light finger holds while it heals.
- Add load slowly. The same slow-loading approach studied in chronic Achilles tendons is applied here.[15]
What do the studies say?
No study — human or animal — has tested BPC-157 or TB-500 on a finger pulley. The research the theory rests on is about a different tissue, in a different species:
- A 2006 rat study found BPC-157 helped a surgically cut Achilles tendon heal.[7]
- A 2011 lab study found it helped tendon cells move, grow, and survive stress in a dish.[8]
- A 2025 review of 544 BPC-157 papers found 35 animal studies and one human study — a small case series on knee pain, not a controlled trial, and nothing about fingers.[9]
- TB-500 has no human trial of its own; the human trials of thymosin β4, the protein it’s a piece of, are for dry eye and use an eye drop.[4]
Bottom line
- Climbers use BPC-157 and TB-500 on a torn pulley on the strength of the lab work — tendon-cell growth, new blood vessels, and a rat Achilles that healed faster.
- What users report is mixed, and the two are nearly always taken together, so it’s hard to credit either one alone.
- No study has tested either one on a pulley, in people or in animals — what exists is animal and cell-culture work.
- The alternative climbers usually get steered to is graded rest and slow, progressive loading.
Frequently asked questions
Has BPC-157 been studied for an A2 pulley injury?
What does a pop on a crimp mean?
Is TB-500 better supported than BPC-157 for this?
References
- Schöffl V, Hochholzer T, Winkelmann HP, Strecker W. Pulley injuries in rock climbers. Wilderness Environ Med. 2003. PMID: 12825883.
- Miro PH, vanSonnenberg E, Sabb DM, Schöffl V. Finger Flexor Pulley Injuries in Rock Climbers. Wilderness Environ Med. 2021. PMID: 33966972.
- Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005. PMID: 16099219. DOI: 10.1016/j.molmed.2005.07.004.
- RegeneRx Biopharmaceuticals (RGN-259 program). Thymosin β4 ophthalmic solution (RGN-259) in dry eye: randomized controlled trial. Clin Ophthalmol. 2015. DOI: 10.2147/OPTH.S80954.
- MESO-Rx forum members BPC-157 — community discussion thread MESO-Rx forum. n.d.. Source.
- MESO-Rx forum members Community peptide lab-testing (Janoshik) thread MESO-Rx forum. n.d.. Source.
- Krivic A, Anic T, Seiwerth S, Huljev D, Sikiric P. Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: promoted tendon-to-bone healing and opposed corticosteroid aggravation. J Orthop Res. 2006. PMID: 16583442. DOI: 10.1002/jor.20096.
- Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011. PMID: 21148156. DOI: 10.1152/japplphysiol.00945.2010.
- Vasireddi N, Hahamyan H, Salata MJ, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J. 2025. PMID: 40756949. DOI: 10.1177/15563316251355551.
- LongeCity forum members BPC-157 — community megathread LongeCity forum. n.d.. Source.
- Attia P AMA #83: Peptides — evaluating the science, safety, and hype The Peter Attia Drive (podcast). n.d.. Source.
- Huberman A Benefits & Risks of Peptide Therapeutics for Physical & Mental Health Huberman Lab (podcast). n.d.. Source.
- U.S. Food and Drug Administration 19 peptides placed in Category 2 of the interim 503A bulks list (safety concerns: immunogenicity, peptide-related impurities) FDA regulatory action, Sept 29, 2023. 2023. Source.
- Cook JL, Purdam CR. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. Br J Sports Med. 2009. PMID: 18812414. DOI: 10.1136/bjsm.2008.051193.
- Alfredson H, Pietilä T, Jonsson P, Lorentzon R. Heavy-load eccentric calf muscle training for the treatment of chronic Achilles tendinosis. Am J Sports Med. 1998. PMID: 9617396. DOI: 10.1177/03635465980260030301.